Security key
640671400
NEPHROS INC - Common Stock - $0.001 par value (NEPH)
CUSIP: 640671400
Q2 2020 13F Holders as of 30 Jun 2020
- Security type / class
- Equity / Common Stock - $0.001 par value
- Total 13F shares
- 4,502,818
- Total 13F value
- $37,780,000
- Share change
- +129,327
- SEC-reported price per share
- $8.39
- Number of holders
- 17
- Value change
- +$1,367,226
- Number of buys
- 6
- Number of sells
- 7
- Shares outstanding
- 10,630,964
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2020
Institutions
17
Top holders
10
NEPH full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2020
Previous quarter: Q1 2020
NEPHROS INC SEC filings
NEPHROS INC company facts
Broader feeds
Reporting periods
Holder history for CUSIP 640671400
Recent filing periods:
Ownership snapshot
Top reported holders of NEPH - NEPHROS INC - Common Stock - $0.001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
WEXFORD CAPITAL LP
Disclosed value leader
WEXFORD CAPITAL LP
Comparable rows
15/15
Latest evidence
31 Mar 2020
13F
Lead comparable stake: 32%
Showing 1-6 of 15 holder rows.
Quick read
WEXFORD CAPITAL LP leads the comparable SEC ownership view at 32%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens WEXFORD CAPITAL LP's linked filing trail.
Comparable ownership
Top 5
WEXFORD CAPITAL LP
32%
Parkman Healthcare Partners LLC
2.4%
BARD ASSOCIATES INC
2%
Cowen Prime Services LLC
1.5%
INGALLS & SNYDER LLC
1.3%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| WEXFORD CAPITAL LP |
13F
Company
|
32%
|
$21,391,000
3,395,579 shares
|
— | 31 Mar 2020 |
| Parkman Healthcare Partners LLC |
13F
Company
|
2.4%
|
$1,584,000
251,366 shares
|
— | 31 Mar 2020 |
| BARD ASSOCIATES INC |
13F
Company
|
2%
|
$2,640,000
207,569 shares
|
— | 31 Mar 2020 |
| Cowen Prime Services LLC |
13F
Company
|
1.5%
|
$975,000
154,800 shares
|
— | 31 Mar 2020 |
| INGALLS & SNYDER LLC |
13F
Company
|
1.3%
|
$839,000
133,140 shares
|
— | 31 Mar 2020 |
| VANGUARD GROUP INC |
13F
Company
|
0.53%
|
$357,000
56,737 shares
|
— | 31 Mar 2020 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2020
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
17
Shares
4,502,818
Rows available
17
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2020 vs Q1 2020 Across Filers
Q1 2020 holders
18
Q2 2020 holders
17
Holder diff
-1
| Investor | Q1 2020 Shares | Q2 2020 Shares | Share Diff | Share Chg % | Q1 2020 value | Q2 2020 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend